Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: Detection of oxidatively modified proteins in substantia nigra

Journal of Neurochemistry

Volumn 68, Issue 6, 1997, Pages 2458-2468

  Venero, José L ^a   Revuelta, Mati ^a   Cano, Josefina ^a   Machado, Alberto ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Apoptosis; Axotomy; Carbonyl groups; Dopaminergic system; Necrosis; Oxidative stress; Striatum; Substantia nigra

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFORMATIONAL TRANSITION; DOPAMINERGIC SYSTEM; FEMALE; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; RAT; SUBSTANTIA NIGRA;

EID: 0031011896     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68062458.x     Document Type: Article

References (48)

1. Ahn B., Rhee S. G., and Stadtman E. R. (1987) Use of fluorescein hydrazide and fluorescein thiosemicarbazide reagents for the fluorometric determination of protein carbonyl groups and for the detection of oxidized protein on polyacrylamide gels. Anal. Biochem. 161, 245-257.
2. Ayala A. and Cutler R. G. (1996) The utilization of 5-hydroxyl-2-amino valeric acid as a specific marker of oxidized arginine and proline residues in proteins. Free Radic. Biol. Med. 21, 65-80.
3. Azmitia E. C. and Segal M. (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179, 641-668.
4. Banati R. B., Gehrmann J., Schubert P., and Kreutzberg G. W. (1993) Cytotoxicity of microglia. Glia 7, 111-118.
5. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
6. Ben-Shachar D. and Youdim M. B. H. (1991) Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats. J. Neurochem. 57, 2133-2135.
7. Bowling A. C., Schulz J. B., Brown R. H., and Beal M. F. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322-2325.
8. Charriaut-Marlangue C., Aggoun-Zouaoui D., Represa A., and Ben-Ari Y. (1996) Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci 19, 109-114.
9. Cleeter M. W. J., Cooper J. M., and Schapira A. H. V. (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
10. Damier P., Hirsch E. C., Zhang P., Agid Y., and Javoy-Agid F. (1993) Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52, 1-6.
11. Descarries L., Soghomonian J.-J., Garcia S., Doucet G., and Bruno J. P. (1992) Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res. 569, 1-13.
12. Dexter D. T., Wells F. R., Lees A. J., Agid F., Jenner P., and Marsden C. D. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830-1836.
13. Gavrieli Y., Sherman Y., and Ben-Sasson S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
14. Gerlach M., Ben-Shachar D., Riederer P., and Youdim M. B. H. (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63, 793-807.
15. Gilad G. and Reis D. J. (1978) Reversible reduction of tyrosine hydroxylase enzyme protein during the retrograde reaction in mesolimbic dopaminergic neurons. Brain Res. 149, 141-153.
16. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
17. 3H]-dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63, 1126-1132.
18. Heikkila R. E. and Cohen G. (1972) Further studies on generation of hydrogen peroxide by 6-hydroxydopamine: potentiation by ascorbic acid. Mol Pharmacol. 8, 241-248.
19. Knüsel B., Beck K D., Winslow J. W., Rosenthal A., Burton L. E., Widmer H. R., Nikolics K., and Hefti F. (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic neurons but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12, 4391-4402.
20. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
21. Lawson L. J., Perry V. H., Dri P., and Gordon S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170.
22. Lenz A. G., Costabel U., Shaltiel S., and Levine R. L. (1989) Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride. Anal. Biochem. 177, 419-425.
23. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B., Shaltiel S., and Stadtman R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478.
24. Liu J. and Mori A. (1993) Monoamine metabolism provides an antioxidant defense in the brain against oxidant-and free radical-induced damage. Arch. Biochem. Biophys. 302, 118-127.
25. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
26. McGeer P. L., Itagaki S., Boyes B. E., and McGeer E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
27. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., and Kagawa Y. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
28. Niijima K., Chalmers G. R., Peterson D. A., Fisher L. J., Paterson P. H., and Gage F. H. (1995) Enhanced survival and neuronal differentiation of adrenal chromaffin cells cografted into the striatum with NGF-producing fibroblasts. J. Neurosci. 15, 1180-1194.
29. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
30. Portera-Cailliau C., Hedreen J. C., Price D. L., and Koliatsos V. E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
31. Qiao X., Hughes P. E., Venero J. L., Dugich-Djordjevic M., Nichols N. R., Hefti F., and Knüsel B. (1996) NT-4/5 protects against adrenalectomy-induced apoptosis of rat hippocampal granule cells. Neuroreport 7, 682-686.
32. 3H]-tyrosine by charcoal. Life Sci. 39, 2185-2189.
33. Reis D. J. and Ross R. A. (1973) Dynamic changes in dopamine-β-hydroxylase activity during the anterograde and retrograde reaction to injury of central noradrenergic axons. Brain Res. 57, 307-326.
34. Reis D. J., Gilad G., Pickel V. M., and Joh T. H. (1978) Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods. Brain Res. 144, 325-342.
35. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G. P., Jellinger K., and Youdim M. B. H. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
36. Ross R. A., Joh T. H., and Reis D. J. (1975) Reversible changes in the accumulation and activities of tyrosine hydroxylase and dopamine-β-hydroxylase in neurons of nucleus locus ceruleus during the retrograde reaction. Brain Res. 92, 57-72.
37. Shirao T., Evinger M. J., Iacovitti L., and Reis D. J. (1992) Lesions of nigrostriatal pathway reduce expression of tyrosine hydroxylase gene in residual dopaminergic neurons of substantia nigra. Neurosci. Lett. 141, 208-212.
38. Simonian N. A. and Coyle J. T. (1996) Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36, 83-106.
39. Snyder A. M., Zigmond M. I., and Lund R. D. (1986) Sprouting of serotoninergic afferent into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and inmunocytochemical study. J. Comp. Neurol 245, 274-281.
40. Sofic E., Paulus W., Jellinger K., Riederer P., and Youdim M. B. H. (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brain. J. Neurochem. 56, 978-982.
41. Stachowiak M. K., Bruno J. P., Snyder A. M., Stricker E. M., and Zigmond M. J. (1984) Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291, 164-167.
42. Stadtman E. R. (1986) Oxidation of proteins by mixed-function oxidation systems: implication in protein turnover, ageing and neutrophil function. Trends Biochem. Sci. 11, 11-12.
43. Stadtman E. R. (1990) Metal ion-catalized oxidation of protein: biochemical mechanism and biological consequences. Free Radic. Biol. Med. 9, 315-325.
44. Stadtman E. (1993) Oxidation of free amino acid residues in proteins by radiolysis and by metal catalyzed reactions. Annu. Rev. Biochem. 62, 797-821.
45. Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
46. Van der Kooy D. and Hattori T. (1980) Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescence retrograde double labeling study in the rat. Brain Res. 186, 1-7.
47. Venero J. L., Santiago M., Machado A., and Cano J. (1989) Determination of monoamines and both forms of monoamine oxidase in the rat's substantia nigra during postnatal development. Life Sci. 45, 1277-1283.
48. Wyllie A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556.